Form 8-K - Current report:
SEC Accession No. 0001493152-26-045603
Filing Date
2026-10-02
Accepted
2026-10-02 17:20:11
Documents
11
Period of Report
2026-10-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37006
  Complete submission text file 0001493152-26-045603.txt   203644

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20261001.xsd EX-101.SCH 3023
3 XBRL LABEL FILE tnxp-20261001_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE tnxp-20261001_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3209
Mailing Address 200 CONNELL DRIVE, SUITE 3100 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE, SUITE 3100 BERKELEY HEIGHTS NJ 07922 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 261437946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)